I think another driver is the fact that we have a small market. If I have a little company and I have a product to sell, I'm not going to bother with Canada first. I'm going to go and do it in America, where the market is huge.
We're really sort of an inconsequential player in the approval process. I don't think much gets approved here, usually, and that's just for business reasons, not for regulatory reasons, etc. I mean, it's just obvious; you have a ginormous market and a little market.
Our regulators in the drug approval stuff tend to be a little more cautious. They tend to be under-resourced compared with those in America. I think we get our medicines fast enough. If you go too fast, it's risky, and if you go too slow, it's risky. We probably have the right balance.
But you have to remember perspective, right? Very few times will Canada be the launch point for one of these technologies, purely because our market is small.